Bacil Pharma Limited (BOM:524516)

India · Delayed Price · Currency is INR

12.30

+0.44 (3.71%)

At close: Aug 21, 2026

Bacil Pharma Financials Overview

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Revenue & Profits

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Gross Profit	-9.14	-	-	-	-	-
Operating Income	-10.73	-2.45	-2.53	-1.89	-1.8	-1.59
Net Income	8.7	15.56	4.04	-0.59	-1.02	-38.6
Earnings Per Share	-	1.11	0.64	-0.10	-0.17	-6.55
EPS Growth	-	73.44%	-	-	-	-

Cash & Debt

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Cash & Investments	5.69	5.69	28.57	0.41	2.2	3.06
Total Debt	-	-	1.64	0.98	0.21	0.33
Net Cash (Debt)	5.69	5.69	26.93	-0.57	1.99	2.73
Net Cash Growth	-78.89%	-78.89%	-	-	-27.11%	338.69%
Net Cash Per Share	-	0.41	4.27	-0.10	0.33	0.46

Cash Flow & CapEx

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Operating Cash Flow	-	7.12	4.01	-0.03	-1.48	-40.09
Capital Expenditures	-	-	-	-	-	-
Free Cash Flow	-	7.12	4.01	-0.03	-1.48	-40.09
Free Cash Flow Growth	-	77.55%	-	-	-	-

Valuation

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Aug '26 Aug 23, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
PE Ratio	20.28	44.04	150.92	-	-	-
P/FCF Ratio	24.81	96.27	152.16	-	-	-